Cost-Effectiveness of Migraine Prevention: The Case of Topiramate in the UK
Authors:
Open Access
- 1 December 2006
- journal article
- Published by SAGE Publications in Cephalalgia
- Vol. 26 (12) , 1473-1482
Abstract
The aim of this study was to assess the cost-effectiveness of topiramate vs. no preventive treatment in the UK. Model inputs included baseline migraine frequency, treatment discontinuation and response, preventive and acute medical cost per attack [2005 GBP (£)] and gain in health utility. Outcomes included monthly migraines averted, acute and preventive treatment costs and cost per quality-adjusted life year (QALY). Topiramate was associated with 1.8 fewer monthly migraines and a QALY gain of 0.0384. The incremental cost of topiramate vs. no preventive treatment was about £10 per migraine averted and £5700 per QALY. Results are sensitive to baseline monthly migraine frequency, triptan use rate and the gain in utility. Incorporating savings from reduced work loss (about £36 per month) suggests that topiramate would be cost saving compared with no preventive treatment. This analysis suggests that topiramate is a cost-effective treatment for migraine prevention compared with no preventive treatment.Keywords
This publication has 30 references indexed in Scilit:
- Burden of Illness and Satisfaction With Care Among Patients With Headache Seen in a Primary Care SettingHeadache: The Journal of Head and Face Pain, 2005
- The Prevalence and Disability Burden of Adult Migraine in England and their Relationships to Age, Gender and EthnicityCephalalgia, 2003
- Patterns of health care utilization for migraine in England and in the United StatesNeurology, 2003
- Burden of Migraine in the United StatesArchives of internal medicine (1960), 1999
- Medical Consultation for Migraine: Results From the American Migraine StudyHeadache: The Journal of Head and Face Pain, 1998
- SumatriptanPharmacoEconomics, 1997
- Burden of MigrainePharmacoEconomics, 1997
- Economic and social impact of migraineQJM: An International Journal of Medicine, 1996
- The Burden of MigrainePharmacoEconomics, 1994
- Impact of Migraine and Tension-Type Headache on Life-Style, Consulting Behaviour, and Medication Use: A Canadian Population SurveyCanadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 1993